• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An emerging role of inflammatory biomarker (suPAR) for prognostic evaluation of atrial fibrillation.

作者信息

Jena Nihar

机构信息

Department of Interventional Cardiology Marshall University Huntington West Virginia USA.

出版信息

J Arrhythm. 2025 Jun 16;41(3):e70116. doi: 10.1002/joa3.70116. eCollection 2025 Jun.

DOI:10.1002/joa3.70116
PMID:40524855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12168478/
Abstract
摘要

相似文献

1
An emerging role of inflammatory biomarker (suPAR) for prognostic evaluation of atrial fibrillation.炎症生物标志物（可溶性尿激酶型纤溶酶原激活物受体）在心房颤动预后评估中的新作用。
J Arrhythm. 2025 Jun 16;41(3):e70116. doi: 10.1002/joa3.70116. eCollection 2025 Jun.
2
Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.血清可溶性尿激酶型纤溶酶原激活物受体与心房颤动之间的关联
J Arrhythm. 2017 Oct;33(5):469-474. doi: 10.1016/j.joa.2017.05.003. Epub 2017 May 30.
3
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation.可溶性尿激酶型纤溶酶原激活物受体（suPAR）作为急性入院房颤患者的预后生物标志物。
J Arrhythm. 2025 Apr 23;41(2):e70077. doi: 10.1002/joa3.70077. eCollection 2025 Apr.
4
Preoperative Levels of the Soluble Urokinase-Type Plasminogen Activator Receptor as Predictor for New Episodes of Atrial Fibrillation After Vascular Surgery.血管手术后可溶性尿激酶型纤溶酶原激活物受体水平与新发心房颤动的预测。
Vasc Endovascular Surg. 2021 Jul;55(5):461-466. doi: 10.1177/1538574421995321. Epub 2021 Feb 24.
5
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.可溶性尿激酶型纤溶酶原激活物受体（suPAR）作为新发心房颤动的预测指标
J Atr Fibrillation. 2018 Apr 30;10(6):1801. doi: 10.4022/jafib.1801. eCollection 2018 Apr.
6
Soluble Urokinase-Type Plasminogen Activator Receptor and Inflammatory Biomarker Response with Prognostic Significance after Acute Neuronal Injury - a Prospective Cohort Study.急性神经元损伤后具有预后意义的可溶性尿激酶型纤溶酶原激活物受体及炎症生物标志物反应——一项前瞻性队列研究
Inflammation. 2024 Nov 14. doi: 10.1007/s10753-024-02185-1.
7
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.可溶性尿激酶型纤溶酶原激活物受体（suPAR）作为全身性慢性炎症的生物标志物。
Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021.
8
Left Atrial Phasic Function in Older Adults Is Associated with Fibrotic and Low-Grade Inflammatory Pathways.老年人左房时相功能与纤维化和低度炎症途径相关。
Gerontology. 2023;69(1):47-56. doi: 10.1159/000522632. Epub 2022 Mar 22.
9
Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.为什么高 suPAR 不是超级——新型生物标志物在 ICU 中的诊断、预后和潜在致病特性。
Crit Care. 2011;15(6):1020. doi: 10.1186/cc10577. Epub 2011 Dec 15.
10
Evaluation of suPAR as a Key Prognostic Biomarker in Patients with SARS-CoV-2 Pneumonia.评估可溶性尿激酶型纤溶酶原激活物受体（suPAR）作为新型冠状病毒肺炎患者关键预后生物标志物的作用
Biomedicines. 2025 Apr 8;13(4):896. doi: 10.3390/biomedicines13040896.

本文引用的文献

1
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation.可溶性尿激酶型纤溶酶原激活物受体（suPAR）作为急性入院房颤患者的预后生物标志物。
J Arrhythm. 2025 Apr 23;41(2):e70077. doi: 10.1002/joa3.70077. eCollection 2025 Apr.
2
Atrial Fibrillation: A Review.心房颤动：综述
JAMA. 2025 Jan 28;333(4):329-342. doi: 10.1001/jama.2024.22451.
3
Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.可溶性尿激酶型纤溶酶原激活物受体对疑似心肌梗死患者死亡率的预测价值。
Clin Res Cardiol. 2019 Dec;108(12):1386-1393. doi: 10.1007/s00392-019-01475-1. Epub 2019 Apr 16.
4
Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.血清可溶性尿激酶型纤溶酶原激活物受体与心房颤动之间的关联
J Arrhythm. 2017 Oct;33(5):469-474. doi: 10.1016/j.joa.2017.05.003. Epub 2017 May 30.
5
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.循环可溶性尿激酶型纤溶酶原激活物受体水平与外周动脉疾病结局的关系。
Atherosclerosis. 2017 Sep;264:108-114. doi: 10.1016/j.atherosclerosis.2017.06.019. Epub 2017 Jun 8.
6
Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.血浆可溶性尿激酶型纤溶酶原激活物受体水平升高与心力衰竭的发生有关，但与心房颤动无关。
Eur J Heart Fail. 2014 Apr;16(4):377-83. doi: 10.1002/ejhf.49.